These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28027004)

  • 21. THE changing seroepidemiology of varicella in Japan: 1977-1981 and 2001-2005.
    Ueno-Yamamoto K; Tanaka-Taya K; Satoh H; Araki K; Kaku M; Okabe N
    Pediatr Infect Dis J; 2010 Jul; 29(7):667-9. PubMed ID: 20228693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt.
    Ibrahim EG; Abdel Wahed WY; Eid HM; Deeb WS
    J Egypt Public Health Assoc; 2019; 94(1):2. PubMed ID: 30686830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia.
    Bartoloni A; Bartalesi F; Roselli M; Mantella A; Dini F; Carballo ES; Barron VP; Paradisi F
    Trop Med Int Health; 2002 Jun; 7(6):512-7. PubMed ID: 12031073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroepidemiology of varicella in Hangzhou, China in the vaccine era.
    Xu Y; Liu S; Che X; Liu Y; Zhang X; Du J; Zhang X; Wang J; Xu E
    Hum Vaccin Immunother; 2018; 14(10):2464-2471. PubMed ID: 30019992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroepidemiology of varicella-zoster in Pakistan.
    Akram DS; Qureshi H; Mahmud A; Khan AA; Kundi Z; Shafi S; N-ur-Rehman ; Olowokure B; Weil J; Bock H; Yazdani I
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):646-9. PubMed ID: 11414405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of varicella-zoster virus in Korea.
    Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
    J Med Virol; 2010 Dec; 82(12):2123-6. PubMed ID: 20981803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
    Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
    Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
    Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
    Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella seroprevalence in a random sample of the Turkish population.
    Kanra G; Tezcan S; Badur S;
    Vaccine; 2002 Jan; 20(9-10):1425-8. PubMed ID: 11818162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella seroprevalence in Turkish population in Cyprus.
    Kurugol Z; Koturoglu G; Aksit S; Ozacar T
    Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of ten years of infant universal Varicella vaccination in Sicily, Italy (2003-2012).
    Amodio E; Tramuto F; Cracchiolo M; Sciuto V; De Donno A; Guido M; Rota MC; Gabutti G; Vitale F
    Hum Vaccin Immunother; 2015; 11(1):236-9. PubMed ID: 25483542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of varicella zoster virus infections in Colombo district, Sri Lanka.
    Liyanage NP; Fernando S; Malavige GN; Mallikahewa R; Sivayogan S; Jiffry MT; Vitarana T
    Indian J Med Sci; 2007 Mar; 61(3):128-34. PubMed ID: 17337813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence and force of infection of varicella-zoster virus in Luxembourg.
    Mossong J; Putz L; Schneider F
    Epidemiol Infect; 2004 Dec; 132(6):1121-7. PubMed ID: 15635970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland.
    Koskiniemi M; Lappalainen M; Schmid DS; Rubtcova E; Loparev VN
    Clin Vaccine Immunol; 2007 Sep; 14(9):1057-61. PubMed ID: 17626161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of varicella in the French population.
    Khoshnood B; Debruyne M; Lançon F; Emery C; Fagnani F; Durand I; Floret D
    Pediatr Infect Dis J; 2006 Jan; 25(1):41-4. PubMed ID: 16395101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence and Risk Factors of Varicella Zoster Infection in Iranian Adolescents: A Multilevel Analysis; The CASPIAN-III Study.
    Hoseini SG; Kelishadi R; Kasaeian A; Ataei B; Yaran M; Motlagh ME; Heshmat R; Ardalan G; Safari O; Qorbani M; Mostafavi SN
    PLoS One; 2016; 11(6):e0158398. PubMed ID: 27355931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012.
    Tafuri S; Fortunato F; Cappelli MG; Cozza V; Bechini A; Bonanni P; Martinelli D; Prato R
    Hum Vaccin Immunother; 2015; 11(1):214-9. PubMed ID: 25483538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A seroprevalence survey on varicella among adults in the vaccination era in Apulia (Italy).
    Tafuri S; Gallone MS; Cappelli MG; Gallone MF; Larocca AM; Germinario C
    Vaccine; 2014 Nov; 32(48):6544-7. PubMed ID: 25236583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of varicella-zoster virus in the prevaccine era: a population-based study in Izmir, Turkey.
    Kose S; Mandiracioglu A; Senger SS; Ulu Y; Cavdar G; Gol B; Gurbuz I; Sariavci S; Nohutcu N
    J Infect Public Health; 2013 Apr; 6(2):115-9. PubMed ID: 23537824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Varicella-zoster virus seroprevalence in children between 0-15 years old].
    Savaş S; Dallar Y; Arikan I; Onde U
    Mikrobiyol Bul; 2004; 38(1-2):69-75. PubMed ID: 15293904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.